Bladder cancer, Transitional cell cancer
Results
Phase 3
This trial looked at celecoxib for a very early type of bladder cancer called superficial transitional cell bladder cancer. It was supported by Cancer Research UK.
Recruitment start: 1 November 2007
Recruitment end: 23 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof. J Kelly
Cambridge Laboratories
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Kyowa Hakko UK Limited
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/07/004.
Last reviewed: 4 September 2019
CRUK internal database number: 539
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
